Logo image of DGNX

DIGINEX LTD (DGNX) Stock Fundamental Analysis

NASDAQ:DGNX - Nasdaq - KYG286871044 - Common Stock - Currency: USD

53.81  -4.4 (-7.56%)

Fundamental Rating

0

Taking everything into account, DGNX scores 0 out of 10 in our fundamental rating. DGNX was compared to 283 industry peers in the Software industry. DGNX may be in some trouble as it scores bad on both profitability and health. DGNX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

DGNX had negative earnings in the past year.
DGNX had a negative operating cash flow in the past year.
DGNX Yearly Net Income VS EBIT VS OCF VS FCFDGNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

DGNX has a Return On Assets of -565.67%. This is amonst the worse of the industry: DGNX underperforms 97.17% of its industry peers.
Industry RankSector Rank
ROA -565.67%
ROE N/A
ROIC N/A
ROA(3y)-602.33%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DGNX Yearly ROA, ROE, ROICDGNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

DGNX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DGNX Yearly Profit, Operating, Gross MarginsDGNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 -200 -400 -600 -800 -1K

More info and screens

0

2. Health

2.1 Basic Checks

DGNX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for DGNX remains at a similar level compared to 1 year ago.
Compared to 1 year ago, DGNX has a worse debt to assets ratio.
DGNX Yearly Shares OutstandingDGNX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 5M 10M 15M 20M
DGNX Yearly Total Debt VS Total AssetsDGNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

DGNX has an Altman-Z score of -26.54. This is a bad value and indicates that DGNX is not financially healthy and even has some risk of bankruptcy.
DGNX has a worse Altman-Z score (-26.54) than 93.99% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -26.54
ROIC/WACCN/A
WACC10.93%
DGNX Yearly LT Debt VS Equity VS FCFDGNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 10M -10M -20M

2.3 Liquidity

A Current Ratio of 0.07 indicates that DGNX may have some problems paying its short term obligations.
With a Current ratio value of 0.07, DGNX is not doing good in the industry: 97.53% of the companies in the same industry are doing better.
DGNX has a Quick Ratio of 0.07. This is a bad value and indicates that DGNX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.07, DGNX is not doing good in the industry: 97.53% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.07
Quick Ratio 0.07
DGNX Yearly Current Assets VS Current LiabilitesDGNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 5M 10M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 47.38% over the past year.
The Revenue for DGNX has decreased by -20.07% in the past year. This is quite bad
EPS 1Y (TTM)47.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-233.25%
Revenue 1Y (TTM)-20.07%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-19.04%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DGNX Yearly Revenue VS EstimatesDGNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 500K 1M 1.5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for DGNX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DGNX Price Earnings VS Forward Price EarningsDGNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DGNX Per share dataDGNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

DGNX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DIGINEX LTD

NASDAQ:DGNX (5/30/2025, 8:00:01 PM)

53.81

-4.4 (-7.56%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners8.69%
Ins Owner ChangeN/A
Market Cap1.24B
AnalystsN/A
Price TargetN/A
Short Float %0.42%
Short Ratio1.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 679.61
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.27
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.3
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS0.08
BVpS-0.69
TBVpS-0.69
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -565.67%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-602.33%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.71
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.07
Quick Ratio 0.07
Altman-Z -26.54
F-Score3
WACC10.93%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-233.25%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-20.07%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-19.04%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-10.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y11.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11.15%
OCF growth 3YN/A
OCF growth 5YN/A